V.O. ANDREEVA

Rostov Scientific Research Institute of Obstetrics and Pediatrics, 43 Mechnikova Str., Rostov-on-Don, Russian Federation, 344013

Andreeva V.O. ― D. Med. Sc., Senior Research Associate, e-mail: vandreyeva@mail.ru.

The results of the study of the efficacy and safety of Miramistin® in the treatment of vulvovaginal candidiasis in teenagers are presented. According to clinicoimmunological and laboratory data, positive effect was achieved in 95% of cases, that indicated a pronounced therapeutic activity of the drug. In addition, the drug showed high tolerability and safety.

Key words: vulvovaginal candidiasis, teenage girls, Miramistin.